📣 Ever heard of Type 3 Diabetes? 🤔
➡️ Those with T2DM have ⬆️ risk of Alzheimer’s, some are calling Type 3 diabetes due to the state of insulin resistance in the brain.
💡 Wondering if this trend is involved in #MAFLD ❓
#livertwitter #medtwitter

In the era of Ozempic, it is refreshing that Nature Reviews Gastroenterology & Hepatology, the leading journal in GI, devotes an article and a beautiful cover to the effects of dietary fiber on metabolic health and obesity.

Pills do not replace a healthy lifestyle.

t.ly/L_m2N #livertwitter

Got to proctor our UTSW Gastroenterology Fellowship advanced fellow James D. Haddad, MD, FACP on another EUS guided coil & glue of a large gastric varix. He's becoming a pro!! 🌟🙌💪

Before-->During coil deployment-->After with No Flow

#ByeByeVarix #GITwitter #LiverTwitter

Hepatorenal syndrome:
🔸Why does it happen ?
🔸How to diagnose and grade it ?
🔸How to use terlipressin and when is RRT needed?

This great review in Gastroenterology tells you all.

#livertwitter t.ly/vnI2X

💡 Más info sobre el Curso de Nutrición en Enfermedades Hepáticas: recorriendo el camino del aprendizaje en equipo 🌟
livernut.com.ar/c/cursos
#Martes #Nutrition #evidencia #LiverTwitter #MedTwitter

PSA for the weekend. Get out and walk 150 minutes. Your liver will love you for it. #livertwitter

1/4
📣Pilot OPEN LABEL randomized trial

🔥1 vs 3 days of terli for variceal bleeding
🔥no difference in re🩸 and death

What are the main problems of OPEN LABEL trials? 🧵👇

onlinelibrary.wiley.com/doi/full/10.11…

#livertwitter Manas Vaishnav roypounder.apt

We are saddened by the sudden loss of our colleague Stephen Harrison, especially on the heels of his work that led to the first treatment for #MASH . Watch him discuss his hopes for resmetirom & patients. Our deepest condolences to his family. #livertwitter bit.ly/3JxDZEO

Exciting news! Earlier today, I successfully defended my PhD thesis discussing a novel therapeutic target for #PSC . Huge thanks to everybody who made this possible: my family, my PhD advisors, my lab colleagues and collaborators, and jury members. #livertwitter #lespetitspoissons

Are you a liver disease researcher looking to expedite your clinical trial?

Did you know hepatoSIGHT can help you answer preliminary research questions AND accelerate recruitment?

Learn more on our website 👇

predictivehealthintelligence.co.uk/professionals/…

#LiverTwitter #ClinicalTrials #MedTech

#EASLStudio is back tonight at 18:00 CEST!

Hear from experts Bogdan Procopet, Maria Papp, Atoosa Rabiee & Thomas Reiberger on #portalhypertension 💡

📺: easl.eu/easl-studio-ep…

#LiverTwitter

🎉Congratulations to our IU Gastro team!🎉
The Division will be well represented at Digestive Disease Week this year, with 108 total engagements! 👏🙌
#DDW2024 #GITwitter #LiverTwitter

🤩We summarized the existing pharmacological therapies for #portalhtn in #cirrhosis Juan G Abraldes

🗝️Etiological tx
✅NSBB
✅Vasoactive agents
✅Statin & metformin

In Press here: shorturl.at/iGKRW

#Livertwitter #GITwitter #MedTwitter #medstudenttwitter

We are looking for a hepatologist to join the GI & Hepatology Division - University of Minnesota team! 🔥

Job ID: 354432
hr.myu.umn.edu/psc/hrprd/EMPL…

#livertwitter #GITwitter AASLD #transplant #AcademicTwitter

First time for everything. Today I did it.

I used the ICD-10 for MASH in EPIC

#livertwitter

#ShortCommunication
▶️Impact of post-progression survival in second-line treatment with molecular target agents for unresectable hepatocellular carcinoma

👉doi.org/10.1111/hepr.1…

#HepatolRes #LiverTwitter Wiley Clinical Health

🧐Lo que debes saber sobre colangitis biliar primaria en una #infografía ➡️ journal-of-hepatology.eu/article/S0168-… vía Journal of Hepatology

#livertwitter

🧬 New study unveils a Polygenic Risk Score (PRS) for Primary Biliary Cholangitis, integrating 22 risk SNPs, sex & HLA factors

🎯 PRS significantly predicts #PBC risk, showing strong association & discriminatory ability in two cohorts

🔓 bit.ly/3way5Xd

#livertwitter

Congratulations to our HEPATOLOGY Journal and Liver Transplantation Journal (LTxJournal) 2024 Editorial Fellows! Maya Deeb Icahn School of Medicine at Mount Sinai and Matt Dukewich Keck Medicine of USC USC Division of GI & Liver #LiverTwitter

👋🏼 #livertwitter

Heading to Digestive Disease Week? You are invited to join us at the LFN reception!

📆Sunday, 5/20 6-6:30 pm
📍Renaissance Hotel

See you there! #GITwitter AASLD